For: | Criss CR, Makary MS. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(3): 413-424 [PMID: 36688022 DOI: 10.3748/wjg.v29.i3.413] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v29/i3/413.htm |
Number | Citing Articles |
1 |
Jingxin Yan, Yonghao Wen, Manjun Deng, Bin Ye, Xinlian Liu, Lushun Zhang. Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews. Journal of Hepatocellular Carcinoma 2023; : 1723 doi: 10.2147/JHC.S429352
|
2 |
Elliott L. Fite, Mina S. Makary. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma. Cancers 2024; 16(13): 2430 doi: 10.3390/cancers16132430
|
3 |
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors. Biology 2023; 12(7): 999 doi: 10.3390/biology12070999
|
4 |
Andrei M. Jipa, Mina S. Makary. Locoregional Therapies for Hepatobiliary Tumors: Contemporary Strategies and Novel Applications. Cancers 2024; 16(7): 1271 doi: 10.3390/cancers16071271
|
5 |
Yu-Bo Zhang, Gang Yang, Yang Bu, Peng Lei, Wei Zhang, Dan-Yang Zhang. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(43): 5804-5817 doi: 10.3748/wjg.v29.i43.5804
Abstract(298) |
Core Tip(314) |
Full Article(HTML)(1451)
|
Full Article with Cover (PDF)-11693K(70)
|
Full Article (Word)-2351K(23)
|
Audio-1157K(3)
|
Peer-Review Report-278K(33)
|
Answering Reviewers-84K(32)
|
Full Article (PDF)-6029K(118)
|
Full Article (XML)-120K(37)
|
Times Cited (6)
|
Total Visits (4355)
|
Open
|
6 |
Jie Lu, Lili Shi, Caiming Zhang, Fabiao Zhang, Miaoguo Cai. Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2385266
|